Generic Name and Formulations:
Yellow fever vaccine live; for SC inj; contains sorbitol, gelatin; preservative-free;.
Sanofi Pasteur, Inc.
Indications for YF-VAX:
Yellow fever immunization.
Adults and Children:
Give at least 10 days before expected exposure; may repeat every 10yrs. <9 months: not recommended. ≥9 months: 0.5mL SC.
Infants <9 months of age. Severe egg allergy (consider skin test and desensitization; see literature). Immunodeficiency or risk of immunosuppression (eg, systemic corticosteroid therapy, chemotherapy, radiation). Thymic dysfunction.
Latex allergy. Have epinephrine (1:1000) available. Elderly (increased risk of systemic events; evaluate prior to, and monitor for at least 10 days after, vaccination). Pregnancy (Cat.C). Nursing mothers.
Yellow fever vaccine.
Concomitant vaccines: see literature.
Injection site reactions, rash, headache, malaise, myalgia, fever; rare neurotropic or viscerotropic disease.
Available only to Yellow Fever Vaccination Centers.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics